1.     K.
Sako, T. Sawada, H. Nakashima, S. Yokohama, T. Sonobe, Influence of water
soluble fillers in hydroxypropylmethylcellulose matrices on in vitro and in
vivo drug release, J. Control. Release 81 (2002) 165-172.
2.      A. Moroni, A novel copovidone binder for dry
granulation and direct-compression tableting, Pharm. Technol. 25 (2001) 8-13.
3.     Amidon
GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic
drug classification: The correlation of in vitro drug product dissolution and
in vivo bioavailability. Pharm Res. 1995;12(3):413-20.
4.     Kim
S, Wei C, Kiang S. Crystallization Process Development of an Active
Pharmaceutical Ingredient and Particle Engineering via the Use of Ultrasonics
and Temperature Cycling. Org Process Res Dev. 2003;7(6):997-1001.
5.     Waknis
V, Chu E, Schlam R, Sidorenko A, Badawy S, Yin S, Narang AS. Molecular basis of
crystal morphology-dependent adhesion behavior of mefenamic acid during
tableting. Pharm Res. 2014;31(1):160-72.
6.     Dalziel
G, Nauka E, Zhang F, Kothari S, Xie M. Assessment of granulation technologies
for an API with poor physical properties. Drug DevInd Pharm. 2013;39(7):985-95
7.     Cole
ET, Cadé D, Benameur H. Challenges and opportunities in the encapsulation of
liquid and semi-solid formulations into capsules for oral administration. Adv
Drug Deliver Rev. 2008;60(6):747-56.
8.     Merck
Index (12th Edition). Budavari, editor. Whitehouse Station, NJ.: Merck Research
Laboratories; 1996.
9.     Wells
JI. Pharmaceutical Preformulation: The Physicochemical Properties of Drug
Substances. Rubinstein MH, editor. Chichester: Ellis Horwood Limited; 1988
10.   United States Pharmacopeia and National
Formulary. USP 36-NF 31. Rockville, MD.: United States Pharmacopeia Convention;
2013. p. 1174 Powder Flow.
11.  Jenike
A. Storage and Flow of Solids. Utah, University of. 1964.
12.  Bhardwaj
S, Jain V, Sharma S, Jat RC, Jain S. 2010. Orally disintegrating tablets: a
review. Drug Invent Today. 2:81â88.
13.  Bircan
Y, Comoglu T. 2012. Formulation technologies of orally fast disintegrating
tablets. Marmara Pharm J. 16:77â81.
14.  Rajalakshmi
R, Sireesha A, Lakshmi SM.Inlay Tablet a novel approach. International journal
of advanced pharmaceutics .2011; 1(1): 1-10.
15.  Plachetka
JR, Kothapalli VM, Gilbert DL. Multilayer dosage forms containing NSAIDS and
Triptans. USP7,332,183 B2.2008;1-20.
16.   Daniel KD,HutchinsBM,Elkins CL, Lee H. Solid
Drug Tablets For Implantable Drug Delivery Device US 2013/0129824 A1.2013;1-8.
17.  Arshad,
M.S.; Zafar, S.; Yousef, B.; Alyassin, Y.; Ali, R.; AlAsiri, A.; Pitt, K. A
review of emerging technologies enabling improved solid oral dosage form
manufacturing and processing. Adv. Drug Deliv. Rev. 2021, 178, 113840. [Google
Scholar] [CrossRef] [PubMed].
18.  Andrews,
G.P. Advances in solid dosage form manufacturing technology. Philos. Trans. R.
Soc. A Math. Phys. Eng. Sci. 2007, 365, 2935â2949. {Google Schola}
19.  Dey
S, ChattopadhyayS,Mazumder B. Formulation and Evaluation of Fixed-Dose
combination of BilayerGastroretentive Matrix Tablet Containing Atorvastatin as
Fast-Release and Atenolol as SustainedRelease.BioMed Research
International.2014; 12.
20.  Audrkzet
MP, Bonduelle M. 1993. Review article on orally disintegrating tablets. J Young
Pharm. 20:372â378.
21.  Awasthi
R, Sharma G, Dua K, Kulkarni GT. 2013. Fast disintegrating drug delivery
systems: a review with special emphasis on fast disintegrating tablets. J
Chronother Drug Deliv. 4:15â30.
22.  Batchelor
HK, Marriott JF. 2015. Formulations for children: problems and solutions. Br J
ClinPharmacol.. 79:405â418.
23.  Bhardwaj
S, Jain V, Sharma S, Jat RC, Jain S. 2010. Orally disintegrating tablets: a
review. Drug Invent Today. 2:81â88.
24.   Bi Y, Sunada H, Yonezawa Y, Danjo K, Otsuka A,
IIDA K. 1996. Preparation and evaluation of a compressed tablet rapidly
disintegrating in the oral cavity. Chem Pharm Bull. 44:2121â2127.
25.   Bi YX, Sunada H, Yonezawa Y, Danjo K. 1999.
Evaluation of rapidly disintegrating tablets prepared by a direct compression
method. Drug DevInd Pharm. 25:571â581.
26.  Pahwa
R, Piplani M, Sharma PC, Kaushik D, Nanda S. 2010. Orally disintegrating
tablets-friendly to pediatrics and geriatrics. Arch ApplSci Res. 2:35â48
27.  Petrovick
GF, Kleinebudde P, Breitkreutz J. 2018. Orodispersible tablets containing
tastemasked solid lipid pellets with metformin hydrochloride: influence of
process parameters on tablet properties. Eur J Pharm Biopharm. 12:137â145.
28.  Preis
M. 2015. Orally disintegrating films and mini-tablets-innovative dosage forms
of choice for pediatric use. AAPS PharmSciTech. 16:234â241.
29.  Rahman
Z, Zidan AS, Khan MA. 2010. Risperidone solid dispersion for orally disintegrating
tablet: its formulation design and nondestructive methods of evaluation. Int J
Pharm. 400:49â58.
30.  Rao
Y, Bandari S, Mittapalli R, Gannu R. 2008. Orodispersible tablets: an overview.
Asian J Pharm. 2:2â25.
31.  Sastry
S, Nyshadham J, Fix J. 2000. Recent technological advances in oral drug
delivery â a review. Pharm SciTechnol Today. 3: 138â145
32.  Rohit
S Gupta, Ratnadeep R Deshmukh, Priyanka U Randive, Akshay V Kshirsagar,
Jaypalsing N Kayte (2018) Study of Phar
33.  Mudie
DM, Amidon GL, Amidon GE. Physiological parameters for oral delivery and in
vitro testing. Mol Pharm 2010;7(5):1388â1405.
34.  K.
Marshall, E.M. Rudnic, in: G.S. Banker, C.T. Rhodes (Eds.), Drugs and the
Pharmaceutical Sciences: Modern Pharmaceutics, vol. 121, Marcel Dekker, New
York, 1990, pp. 23â66.
35.  I.
Gomez-Orellana, Strategies to improve oral drug bioavailability, Expert
Opin.DrugDeliv. 2 (2005) 419â433
36.  R.
McLaughlin, S. Banbury, K. Crowley, Orally disintegrating tablets. The effect
of recent FDA guidance on ODT technologies applications, Pharm. Technol.(Suppl.)
(20090
37.  Velmurugan
S, Vinushitha S. 2010. Oral disintegrating tablets: an overview. Int J Chem
Pharm Sci. 1:1â12.
38.   Walsh J, Cram A, Woertz K, Breitkreutz J,
Winzenburg G, Turner R, Tuleu C. 2014. Playing hide and seek with poorly
tasting pediatric medicines: do not forget the excipients. Adv Drug Deliv Rev.
73:14â33.
39.  Yadav
D, Mishra A. 2017. Preparation and evaluation of orodispersible tablet of
anti-inflammatory drug celecoxib. J Pharm Pharm Sci. 1:35â39.
40.  Timmins
P, Brown J. Formulation Technology Enables the Delivery of HIV Medicines.
European Industrial Pharmacy Journal. 2013;19 12-7.
41.  Tahami,
K., & Singh, J., (2007). Smart polymer based delivery systems for peptides
and proteins. Rec. Pat. Drug Deliv. Form., 1(1), 65â71
42.  .Anderson,
O., et al., (1995). Problems when swallowing tablets. TidsskrNorLaegeforen.,
115 , 947â949.Arora, S., Ali, J., Ahuja, A., Khar, R., &Baboota, S.,
(2005). Floating drug delivery systems: A review. AAPS Parm. Sci. Tech., 6(3),
E372âE390.
43.  Avery,
S. W., &Dellarosa, D. M., (1994). Approaches to treating dysphagiain
patients with brain injury. Am. J. Occup. Ther., 48, 235â239
44.  .Cherukuri,
S. R., &Fuisz, R., (1995). Process and apparatus for making tablets and
tablets made there from. European Patent, 0677,147A2.
45.  Cherukuri,
S. R., &Fuisz, R., (1997). Process and apparatus for making tablets and
tablets made there from. US Patent 5,654,003.
46.  Shailesh
S. New Generation of Tablet: Fast Dissolving Tablet. Pharmainfo. net. 2008;
6(1)8.   Kumari S, Visht S, Sharma PK,
Yadav RK. Fast dissolving drug delivery system: review article. Journal of
Pharmacy Research. 2010; 3(6): 1444-9.
47.  Ashish
P, Mishra P, Main P, Harsoliya M, Agrawal S. A review on-recent advancement in
the development of rapid disintegrating tablet. Int J Life Sci Pharm Res. 2011;
1: 7-16.
48.  Yadav
G, Kapoor A, Bhargava S. Fast dissolving tablets recent advantages: A review.
International Journal of Pharmaceutical Sciences and Research. 2012; 3(3): 728
49.  Rewar
S, Singh CJ, Bansal BK, Pareek R, Sharma AK. Oral dispersible tablets: An
overview; development, technologies and evaluation. International Journal of
Research and Development in Pharmacy and Life Sciences. 2014; 3(6): 1245-57
50.  Hannan
PA, Khan JA, Khan A, Safiullah S. Oral dispersible system: A new approach in
drug delivery system. Indian Journal of Pharmaceutical Sciences. 2016; 78(1):
2.
51.  Slavkova
M, Breitkreutz J. Orodispersible drug formulations for children and elderly.
European Journal of Pharmaceutical Sciences. 2015; 75: 2-9.
52.  https://www.maximizemarketresearch.com/market-report/oral-solid-dosage-pharmaceutical-formulation-market/121388/
53.  https://images.app.goo.gl/teKMH41ZrqjikBWx7
54.  https://www.google.com/imgres?h=295&w=524&tbnh=168&tbnw=299&osm=1&lns_uv=1&source=lens-native&usg=AI4_-kTak_H5a512fKzCblFGUBE5XVDTlA&imgurl=https://www.losan-pharma.de/wp-content/uploads/2021/02/losan_minitabletten_gelb.jpg&imgrefurl=https://www.losan-pharma.de/manufacturing-services/stick-packs/mini-tablets/&tbnid=b-0q4MguneoRyM&docid=SZMHW9CHugslRM
55.  https://images.app.goo.gl/pnLNLXKzYtuQMjU57
56.  https://www.pharmtech.com/view/optidose-technology
57.  https://images.app.goo.gl/y6DsZkKocvwpFCu26
58.  https://images.app.goo.gl/Wfzw93FDKRJ9ECJR9
59.  https://www.google.com/imgres?h=487&w=800&tbnh=175&tbnw=288&osm=1&lns_uv=1&source=lens-native&usg=AI4_-kTWkqpU_37mgiiSHHDxFteAOu2ESQ&imgurl=https://thumbs.dreamstime.com/b/medical-lozenges-relief-cough-sore-throat-irritation-isolated-white-background-colds-drop-colorful-pastille-red-orange-143208636.jpg&imgrefurl=https://www.dreamstime.com/photos-images/cough-sweets.html&tbnid=hkoVNta3JXNhuM&docid=pV2BdfEiRJ6QlM
60.  https://images.app.goo.gl/7fHzEfQNsMavqN687
61.  https://images.app.goo.gl/Q8dJckP8BjgXmKr66
62.  https://images.app.goo.gl/tKBFSkfmfEgQKMb19
63.  https://images.app.goo.gl/tksLWS2h31vEys399
64.  https://images.app.goo.gl/Wfzw93FDKRJ9ECJR9
65.  https://images.app.goo.gl/nvwvXArtnmJDrvQv9
66.  https://images.app.goo.gl/vtLifTY1KoEWQMEk8
67.  https://images.app.goo.gl/QPpWozN2e6Q7mHkb8